RNA Dysregulation in Amyotrophic Lateral Sclerosis

Area of Science:

• Neuroscience
• Molecular Biology
• Genetics

Background:

• Amyotrophic lateral sclerosis (ALS) is a progressive motor neuron disease.
• Degeneration of motor neurons characterizes ALS.
• RNA dysregulation is increasingly recognized as a key factor in ALS.

Purpose of the Study:

• To review the role of RNA dysregulation in ALS pathogenesis.
• To highlight the involvement of major ALS genes in RNA metabolism.
• To discuss therapeutic strategies targeting disease RNAs for ALS.

Main Methods:

• Literature review focusing on RNA metabolism and ALS.
• Analysis of major ALS-associated genes (SOD1, TARDBP, FUS, C9orf72).
• Examination of RNA processing pathways affected in ALS.

Main Results:

• Major ALS genes are implicated in critical RNA metabolism processes.
• These processes include transcription, splicing, transport, stabilization, and miRNA biogenesis.
• Evidence links altered RNA metabolism to motor neuron degeneration in ALS.

Conclusions:

• RNA dysregulation is a significant contributor to ALS.
• Therapeutic interventions targeting disease-related RNAs show promise for ALS treatment.
• Further research into RNA-centric mechanisms is crucial for developing effective ALS therapies.